A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.
May 31, 2026
0
17
As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a so-called bispecific T-cell ...
May 31, 2026
0
11
In a new study published in JAMA, the diagnostic yield of transbronchial lung biopsy was significantly higher when using a cryoprobe versus forceps in a group of patients with pulmonary nodules or masses, recent lung transplant, ...
May 31, 2026
0
3
Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large international clinical ...
May 31, 2026
0
21
Two patients who recently arrived in Brazil from African countries have been put in isolation after showing symptoms linked to Ebola, officials said, raising concerns about the deadly virus spreading beyond the African continent.
May 31, 2026
0
13
Once confined to niche bodybuilding forums and hardcore gyms, unproven injectable peptides are now being openly marketed online to the average gym-goer by social media influencers—and regulators struggling to keep up.
May 31, 2026
0
10
An outbreak of a rare type of Ebola virus has plagued Congo and Uganda, as cases outpace the response.
May 31, 2026
0
9
A first-in-class PET imaging approach can accurately detect a biomarker for chronic traumatic encephalopathy (CTE), a devastating neurodegenerative disease associated with repeated head impact. Rather than waiting until after ...
May 31, 2026
0
6
Your heart already has its own built-in bypass system that predicts whether the heart muscle is alive or dead—according to new research from the University of East Anglia and Norfolk and Norwich University Hospital.
May 31, 2026
0
6
With the publication of the long-term data from the RELAZA2 study, a research program developed over many years by Dresden University Medicine for the treatment of leukemia patients, has reached an important milestone. The ...
May 31, 2026
0
7
